- - AbbVie in talks to buy biotech Revolution Medicines, WSJ reports

ReutersJanuary 8, 2026 at 1:30 AM

0

A sign stands outside a Abbvie facility in Cambridge, Massachusetts, U.S., May 20, 2021. REUTERS/Brian Snyder

Jan 7 (Reuters) - AbbVie ​is in ‌advanced talks ‌to buy cancer-drug developer ⁠Revolution ‌Medicines, the Wall ‍Street Journal reported on Wednesday, ​citing ‌people familiar with the matter.

Shares of Revolution ⁠were ​up ​10% in afternoon trading.

(Reporting ‍by ⁠Puyaan Singh in ⁠Bengaluru; Editing ‌by Alan ‌Barona)

Original Article on Source

Source: “AOL Money”